tu ber ku lo zi sa da aiv koin feq ci is mar Tva

The program aimed to improve TB diagnosis and treatment outcomes among people living with HIV (PLHIV) in Rwanda. Key interventions included the implementation of Xpert MTB/RIF, a rapid diagnostic test for TB, and the initiation of antiretroviral therapy (ART) for PLHIV. The program also focused on improving TB/HIV diagnosis and treatment outcomes through the use of CD4 count and TB/HIV co-infection diagnosis. The program's results showed a significant increase in TB/HIV diagnosis and treatment outcomes among PLHIV. The proportion of TB/HIV co-infection among TB patients increased from 2.8% to 8.2% after the implementation of the program. The proportion of TB/HIV co-infection among PLHIV increased from 2.2% to 5.5% after the implementation of the program. The program also showed a significant increase in the proportion of PLHIV who initiated ART, from 2.2% to 5.5%. The proportion of PLHIV who initiated ART and had a CD4 count of 200 cells/mm3 or higher increased from 1.1% to 2.5%. The program's results also showed a significant decrease in the proportion of TB/HIV co-infection among TB patients who were not on ART, from 4.5% to 1.1%. The proportion of TB/HIV co-infection among PLHIV who were not on ART decreased from 3.3% to 1.1%.